CNR Institutional Research Information System

SARTORIUS, ROSSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 213
AS - Asia 133
EU - Europa 46
Totale 392
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 213
SG - Singapore 94
CN - Cina 26
FI - Finlandia 22
IT - Italia 14
KR - Corea 12
DE - Germania 10
HK - Hong Kong 1
Totale 392
Salva come PNG Salva come JPEG
Città #
Santa Clara 192
Singapore 69
Helsinki 22
Seoul 12
Falkenstein 10
Avellino 7
Rome 4
Boardman 3
Bologna 2
Forest City 1
Hong Kong 1
Naples 1
Totale 324
Salva come PNG Salva come JPEG
Nome #
300x100: Protagoniste per la ricerca 11
Mesoporous Bioactive Glasses in Cancer Diagnosis and Therapy: Stimuli-Responsive, Toxicity, Immunogenicity, and Clinical Translation 10
Vaccination with Filamentous Bacteriophages trageting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 10
PHAGE CONJUGATES AND USES THEREOF 9
Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants 9
E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells. 9
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 9
Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells 8
Vectorized delivery of alpha-GalactosylCeramide and tumor antigen on filamentous bacteriophage fd induces protective immunity by enhancing tumor-specific T cell. 8
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies 8
Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy 8
Give a selfie for women @CNR 8
Induction of human NK cell-mediated cytotoxicity by CD40 triggering on antigen presenting cells. 8
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 8
Phage display of epitopes from HIV-1 elicits strong cytolytic responses in vitro and in vivo 8
Immunostimulatory Phosphatidylmonogalactosyldiacylglycerols (PGDG) from the marine diatom Thalassiosira weissflogii: Inspiration for a novel synthetic toll-like receptor 4 agonist 7
ImmuNapoli 2016 7
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 7
Engineering and Development of a Tissue Model for the Evaluation of Microneedle Penetration Ability, Drug Diffusion, Photothermal Activity, and Ultrasound Imaging: A Promising Surrogate to Ex Vivo and In Vivo Tissues 7
Arming filamentous bacteriophage, aNature-made nanoparticles, for new vaccine and immunotherapeutic strategies 7
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines 7
ImmuNapoli 2019 7
Searching for new vaccine vectors: E2 protein from B. stearothermophilus PDH complex. 6
Filamentous bacteriophage: an antigen and gene delivery system 6
Filamentous bacteriophages targeting DEC-205 induce dendritic cell maturation and potent T cell response in absence of adjuvants 6
An Ig Transmembrane Domain Motif Improves the Function of TCRs Transduced in Human T Cells: Implications for Immunotherapy 6
Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses 6
TLR-9 dependent dendritic cell activation by filamentous bacteriophage targeting DEC-205. 6
Cell loaded hydrogel containing Ag-doped bioactive glass-ceramic nanoparticles as skin substitute: Antibacterial properties, immune response, and scarless cutaneous wound regeneration 6
Recombinant filamentous bacteriophages encapsulated in biodegradable polymeric microparticles for stimulation of innate and adaptive immune responses 6
Antigen delivery by using filamentous bacteriophage FD or a macromolecular scaffold derived from a multienzyme complex 6
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants. 5
Bioengineered materials with selective antimicrobial toxicity in biomedicine 5
Comparative analysis of new innovative vaccine formulations based on the use of procaryotic display systems 5
Comparative analysis of innovative vaccine formulations based on the use of procaryotic display systems. 5
PLGA microparticle formulations for tunable delivery of a nano-engineered filamentous bacteriophage-based vaccine: in vitro and in silico-supported approach 5
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 Neutralizing Antibodies and CD8+ T Cells 5
New recombinant vaccine based on filamentous bacteriophage fd particles targeting DC 5
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 5
Co-immunization with Multimeric Scaffolds and DNA Rapidly Induces Potent Autologous HIV-1 5
Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking 5
Co-immunization with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 5
Filamentous bacteriophages targeting DEC-205 induce DC-maturation and strong T cell responses in absence of adjuvants. 5
Massive-scale RNA-Sequencing of Bone Marrow derived Dendritic Cells exposed to different antigen display systems. 5
Vaccination With Recombinant Filamentous fd Phages Against Parasite Infection Requires TLR 9 Expression 5
The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2 restricted peptides and to induce strong anti-tumor CTL responses 5
Cellular and molecular mechanisms of vaccination by bacteriophages. 5
Filamentous bacteriophages targeting DEC-205 induce DC maturation and durable T cell responses in absence of adjuvants 5
null 5
Nonspherical Metal-Based Nanoarchitectures: Synthesis and Impact of Size, Shape, and Composition on Their Biological Activity 5
Targeting dendritic cells with filamentous bacteriophage fd carriers displaying anti-Dec 205 scFv bypasses the need of adjuvants 5
E2 multimeric scaffold for vaccine formulation: transcriptome analysis of pulsed dendritic cells and immune response by intranasal delivery. 5
Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside 5
Intranasal immunization with E2 multimeric scaffolds displaying the HIV-1 third hypervariable region induces V3-specific IgA antibodies as well as CD4+ T cell responses 5
Long-Term Vaccine Delivery and Immunological Responses Using Biodegradable Polymer-Based Carriers 5
null 4
Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses. 4
Induction of specific T-helper and cytolytic responses to epitopes displayed on a virus-like protein scaffold derived from the pyruvate dehydrogenase multienzyme complex. 4
Coimmunizzation with multimeric E2 scaffolds and DNA rapidly induces potent autologous HIV-1 neutralizing antibodies and CD8+ T cells 4
Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T cell response in absence of adjuvants 4
Stimulation of Innate and Adaptive Immunity by Using Filamentous Bacteriophage fd Targeted to DEC-205. 4
E2 multimeric scaffolds displaying HIV-1 Envelope regions sustain specific neutralizing antibody and T cell responses when combined with gp160 plasmid DNA 4
Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments. 3
Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. 2
Phage display of epitopes from HIV-1 elicits strong cytolytic responses in vitro and in vivo. 2
Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection. 2
Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies 1
Totale 392
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.897
article - articoli 1.186
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 60
Totale 3.143
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202442 0 0 0 0 0 0 0 1 0 2 34 5
2024/2025350 1 4 88 28 193 36 0 0 0 0 0 0
Totale 392